Patrick T. Mooney
Directeur Général chez Linnaeus Therapeutics, Inc.
Profil
Patrick T.
Mooney currently works at Inpellis, Inc., as President, Chief Executive Officer & Director from 2015, Linnaeus Therapeutics, Inc., as Chief Executive Officer & Director, Linnaeus Therapeutics LLC, as Chief Executive Officer, and Footwear Unlimited, Inc., as President.
Dr. Mooney also formerly worked at Aphton Corp., as Chairman, President & Chief Executive Officer from 2004 to 2006, Sontra Medical Corp., as Chairman, President & Chief Executive Officer from 2006 to 2007, Durham Pharmaceuticals, as President & Chief Executive Officer from 2006 to 2007, Echo Therapeutics, Inc., as President & Chief Executive Officer from 2006 to 2007, QuantRx Biomedical Corp., as Director in 2010, Photovoltaic Solar Cells, Inc., as Director in 2012, Echo Therapeutics, Inc., as Director in 2013, MetaStat, Inc., as Independent Director from 2012 to 2014, Thomas Weisel Partners LLC, as Analyst in 2003, and Janney Montgomery Scott LLC, as Vice President.
Dr. Mooney received his undergraduate degree and doctorate degree from Sidney Kimmel Medical College.
Postes actifs de Patrick T. Mooney
| Sociétés | Poste | Début |
|---|---|---|
Footwear Unlimited, Inc.
 Footwear Unlimited, Inc. Apparel/FootwearConsumer Non-Durables Footwear Unlimited, Inc. operates as a footwear manufacturer and wholesaler. The company was incorporated in 1966 and is headquartered in Fenton, MO. | President | 08/10/2009 |
Inpellis, Inc.
 Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ. | Directeur Général | 01/06/2015 |
Linnaeus Therapeutics, Inc.
 Linnaeus Therapeutics, Inc. BiotechnologyHealth Technology Linnaeus Therapeutics, Inc. engages in identification and development of small molecule agents that modulate cellular differentiation for the treatment of cancer and disorders of pigmentation. The company was founded by Christopher Natale and Todd Ridky in 2016 and is headquartered in Haddonfield, NJ. | Directeur Général | - |
Linnaeus Therapeutics LLC
 Linnaeus Therapeutics LLC BiotechnologyHealth Technology Linnaeus Therapeutics LLC is a development-stage biotech company that identifies and develops small molecule agents for the treatment of various cancers. The private company is based in Philadelphia, PA. The company's compounds can be used to increase or decrease pigmentation and provide a UV-protecting tan without DNA damage. The company was founded in 2016 by Christopher Natale, Todd Ridky, and the CEO is Patrick T. Mooney. The company also focuses on modulating melanocyte pigmentation to correct genetic and acquired skin pigmentation conditions. | Directeur Général | - |
Anciens postes connus de Patrick T. Mooney
| Sociétés | Poste | Fin |
|---|---|---|
| METASTAT, INC. | Directeur/Membre du Conseil | 15/10/2014 |
| ECHO THERAPEUTICS, INC. | Directeur Général | 07/10/2013 |
Photovoltaic Solar Cells, Inc.
 Photovoltaic Solar Cells, Inc. Financial ConglomeratesFinance Photovoltaic Solar Cells, Inc. is a development stage company. It engages in identifying, investigating and if warranted, acquiring companies. The company was founded by Lawrence F. Curtin on March 28, 2007 and is headquartered in New York, NY. | Directeur/Membre du Conseil | 20/04/2012 |
| QUANTRX BIOMEDICAL CORPORATION | Directeur/Membre du Conseil | 01/09/2010 |
| Echo Therapeutics, Inc. /Old/ | President | 08/10/2007 |
Formation de Patrick T. Mooney
| Sidney Kimmel Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| QUANTRX BIOMEDICAL CORPORATION | Health Technology |
| METASTAT, INC. | Producer Manufacturing |
| Entreprise privées | 12 |
|---|---|
Aphton Corp.
 Aphton Corp. BiotechnologyHealth Technology Aphton Corp. operates as a biopharmaceutical company, which is focused on the development and commercialization of pharmaceutical products for the treatment of cancer and gastrointestinal disease. The company was founded on May 12, 1981 and is headquartered in Philadelphia, PA. | Health Technology |
Sontra Medical Corp.
 Sontra Medical Corp. Medical SpecialtiesHealth Technology Sontra Medical Corporation engages in the development of transdermal diagnostic and drug delivery products based on its SonoPrep ultrasonic skin permeation technology. SonoPrep is a noninvasive ultrasonic skin permeation technology for medical and therapeutic applications, including transdermal diagnostics and the delivery of drugs through the skin | Health Technology |
Photovoltaic Solar Cells, Inc.
Photovoltaic Solar Cells, Inc. Financial ConglomeratesFinance Photovoltaic Solar Cells, Inc. is a development stage company. It engages in identifying, investigating and if warranted, acquiring companies. The company was founded by Lawrence F. Curtin on March 28, 2007 and is headquartered in New York, NY. | Finance |
Thomas Weisel Partners LLC
 Thomas Weisel Partners LLC Investment Banks/BrokersFinance Founded in 1998, Thomas Weisel Partners (TWP) is a broker/dealer headquartered in San Francisco with offices in New York City, Boston, Denver, Colorado and Palo Alto, California. The firm is a subsidiary of Thomas Weisel Partners Group, Inc. (Nasdaq: TWPG), a San Francisco-based investment banking firm. Their ultimate parent is Stifel Financial Corp. (NYSE: SF). TWP's investment banking, brokerage and equity research divisions serve emerging growth companies and institutional investors around the world. They are a member of the NYSE, the SIPC and FINRA. TWP specializes in the growth sectors of the economy with a particular focus on the consumer, energy, healthcare, Internet, media/telecommunications, metals/mining and technology sectors. Within the consumer sector, the firm focuses on: financial products, gaming/lodging, interactive market services, lifestyles/sports retailers, restaurants and hardlines and softlines retailing. TWP's global energy research is provided by analysts in three countries and covers the following trends: (1) fast-growing oil and natural gas producers in North America and worldwide (2) domestic and international energy service companies and (3) alternative energy technology and resource developers. Within the healthcare sector, TWP focuses on: biotechnology, diagnostics, healthcare information technology, pharmaceutical services, life science technology, medical devices and specialty pharmaceuticals. The firm's interest in the Internet, media and telecommunications sector include: Internet services, media, broadcasting and telecommunications services. Their focus within the metals and mining sector include: base metals, gold, precious metals and uranium. TWP's technology research focuses on: (1) applied technologies (2) communications components (3) core and wireless communications equipment (4) IP networking communications equipment (5) electronic supply chain (6) enterprise hardware (7) information and financial technology services (8) semiconductor capital equipment (9) broadline and specialty semiconductors (10) applications and communications software and (11) infrastructure software. TWP also provides value-added equities analysis across a variety of sectors including: industrials, financials, consumer, technology and healthcare. | Finance |
Janney Montgomery Scott LLC
 Janney Montgomery Scott LLC Investment Banks/BrokersFinance Founded in 1999 by the late Thomas Watson, Janney Montgomery Scott LLC (JMS) is a full-service financial services firm and registered broker/dealer headquartered in Philadelphia, Pennsylvania. The firm is a subsidiary of Independence Square Properties LLC, itself a subsidiary of Penn Mutual Insurance Co. Their ultimate parent is Harleysville Mutual Insurance Co. JMS is a member of the NYSE, the SIPC and FINRA. The firm provides comprehensive financial advice and services to individual, corporate and institutional investors. Their primary coverage verticals include the consumer, technology, financials and infrastructure sectors. | Finance |
| Durham Pharmaceuticals | |
Echo Therapeutics, Inc.
 Echo Therapeutics, Inc. Medical SpecialtiesHealth Technology Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ. | Health Technology |
Footwear Unlimited, Inc.
Footwear Unlimited, Inc. Apparel/FootwearConsumer Non-Durables Footwear Unlimited, Inc. operates as a footwear manufacturer and wholesaler. The company was incorporated in 1966 and is headquartered in Fenton, MO. | Consumer Non-Durables |
Inpellis, Inc.
Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ. | Health Technology |
Linnaeus Therapeutics, Inc.
Linnaeus Therapeutics, Inc. BiotechnologyHealth Technology Linnaeus Therapeutics, Inc. engages in identification and development of small molecule agents that modulate cellular differentiation for the treatment of cancer and disorders of pigmentation. The company was founded by Christopher Natale and Todd Ridky in 2016 and is headquartered in Haddonfield, NJ. | Health Technology |
Linnaeus Therapeutics LLC
Linnaeus Therapeutics LLC BiotechnologyHealth Technology Linnaeus Therapeutics LLC is a development-stage biotech company that identifies and develops small molecule agents for the treatment of various cancers. The private company is based in Philadelphia, PA. The company's compounds can be used to increase or decrease pigmentation and provide a UV-protecting tan without DNA damage. The company was founded in 2016 by Christopher Natale, Todd Ridky, and the CEO is Patrick T. Mooney. The company also focuses on modulating melanocyte pigmentation to correct genetic and acquired skin pigmentation conditions. | Health Technology |
| Echo Therapeutics, Inc. /Old/ | Health Technology |